Heat shock protein-based therapy for sphingolipidoses
Lysosomal diseases often manifest with severe systemic and central nervous system (CNS) symptoms. The existing treatment options are limited and have no or only modest efficacy against neurological manifestations of disease. We recently demonstrated that recombinant HSP70 improves the binding of sev...
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
Elsevier
2017
|